
1. Sci Immunol. 2018 Feb 2;3(20). pii: eaao4013. doi: 10.1126/sciimmunol.aao4013.

Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood,
distinguish type 1 diabetic patients from healthy donors.

Culina S(1)(2)(3), Lalanne AI(1)(2)(3), Afonso G(1)(2)(3), Cerosaletti K(4),
Pinto S(5), Sebastiani G(6), Kuranda K(1)(2)(3), Nigi L(6), Eugster A(7),
Østerbye T(8), Maugein A(1)(2)(3), McLaren JE(9), Ladell K(9), Larger
E(1)(2)(3)(10), Beressi JP(11), Lissina A(12)(13), Appay V(12)(13), Davidson
HW(14), Buus S(8), Price DA(9)(15), Kuhn M(16), Bonifacio E(7), Battaglia M(17), 
Caillat-Zucman S(18), Dotta F(6), Scharfmann R(1)(2)(3), Kyewski B(5), Mallone
R(19)(2)(3)(10); ImMaDiab Study Group.

Collaborators: Carel JC, Tubiana-Rufi N, Martinerie L, Poidvin A, JacqzAigrain E,
Corvez L, Berruer V, Gautier JF, Baz B, Haddadi N, Andreelli F, Amouyal C,
Jaqueminet S, Bourron O, Dasque E, Hartemann A, Lemoine-Yazigi A, Dubois-Laforgue
D, Travert F, Feron M, Rolland P, Vignali V, Marre M, Chanson P, Briet C,
Guillausseau PJ, Ait-Bachir L, Collet C, Beziaud F, Desforges-Bullet V,
Petit-Aubert G, Christin-Maitre S, Fève B, Vatier C, Bourcigaux N, Lautridou C,
Lahlou N, Bakouboula P, Elie C, Morel H, Treluyer JM, Gagnerault MC, Maillard C, 
Jones A.

Author information: 
(1)INSERM, U1016, Cochin Institute, Paris, France.
(2)CNRS, UMR8104, Cochin Institute, Paris, France.
(3)Paris Descartes University, Sorbonne Paris Cité, Paris, France.
(4)Benaroya Research Institute, Translational Research Program, Seattle, WA
98101, USA.
(5)Division of Developmental Immunology, German Cancer Research Center (DKFZ),
Heidelberg, Germany.
(6)Diabetes Unit, Department of Medicine, Surgery and Neuroscience, University of
Siena, and Fondazione Umberto di Mario ONLUS, Toscana Life Sciences, Siena,
Italy.
(7)CRTD-DFG Research Center for Regenerative Therapies Dresden, Medical Faculty, 
Technische Universität Dresden, Dresden, Germany.
(8)Department of International Health, Immunology and Microbiology, Panum
Institute, Copenhagen, Denmark.
(9)Division of Infection and Immunity, Cardiff University School of Medicine,
Cardiff, UK.
(10)Assistance Publique Hôpitaux de Paris, Service de Diabétologie, Cochin
Hospital, Paris, France.
(11)Centre Hospitalier de Versailles André Mignot, Service de Diabétologie, Le
Chesnay, France.
(12)Pierre et Marie Curie Paris 6 University, Sorbonne Paris Cité, Département
Hospitalo-Universitaire FAST, CR7, Centre d'Immunologie et des Maladies
Infectieuses (CIMI-Paris), Paris, France.
(13)INSERM, U1135, CIMI-Paris, Paris, France.
(14)Barbara Davis Center for Diabetes and Integrated Department of Immunology,
University of Colorado Denver Anschutz Medical Campus, Aurora, CO 80045, USA.
(15)Vaccine Research Center, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
(16)Institut für Medizinische Informatik und Biometrie, Medical Faculty,
Technische Universität Dresden, Dresden, Germany.
(17)Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, 
Italy.
(18)Assistance Publique Hôpitaux de Paris, Laboratoire d'Immunologie et
Histocompatibilité, Hôpital Saint-Louis, Paris, France.
(19)INSERM, U1016, Cochin Institute, Paris, France. roberto.mallone@inserm.fr.

The human leukocyte antigen-A2 (HLA-A2)-restricted zinc transporter 8186-194
(ZnT8186-194) and other islet epitopes elicit interferon-γ secretion by CD8+ T
cells preferentially in type 1 diabetes (T1D) patients compared with controls. We
show that clonal ZnT8186-194-reactive CD8+ T cells express private T cell
receptors and display equivalent functional properties in T1D and healthy
individuals. Ex vivo analyses further revealed that CD8+ T cells reactive to
ZnT8186-194 and other islet epitopes circulate at similar frequencies and exhibit
a predominantly naïve phenotype in age-matched T1D and healthy donors. Higher
frequencies of ZnT8186-194-reactive CD8+ T cells with a more antigen-experienced 
phenotype were detected in children versus adults, irrespective of disease
status. Moreover, some ZnT8186-194-reactive CD8+ T cell clonotypes were found to 
cross-recognize a Bacteroides stercoris mimotope. Whereas ZnT8 was poorly
expressed in thymic medullary epithelial cells, variable thymic expression levels
of islet antigens did not modulate the peripheral frequency of their cognate CD8+
T cells. In contrast, ZnT8186-194-reactive cells were enriched in the pancreata
of T1D patients versus nondiabetic and type 2 diabetic individuals. Thus,
islet-reactive CD8+ T cells circulate in most individuals but home to the
pancreas preferentially in T1D patients. We conclude that the activation of this 
common islet-reactive T cell repertoire and progression to T1D likely require
defective peripheral immunoregulation and/or a proinflammatory islet
microenvironment.

Copyright © 2018 The Authors, some rights reserved; exclusive licensee American
Association for the Advancement of Science. No claim to original U.S. Government 
Works.

DOI: 10.1126/sciimmunol.aao4013 
PMCID: PMC5874133
PMID: 29429978  [Indexed for MEDLINE]

